ISSN: 2157-2526

Journal of Bioterrorism & Biodefense
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Bioterr Biodef 2025, Vol 16(4): 04.464

Next-Gen Vaccines: Progress, Challenges, Future Solutions

Dr. Isabella Romano*
Department of Immunology University of Rome, Rome, Italy
*Corresponding Author : Dr. Isabella Romano, Department of Immunology University of Rome, Rome, Italy, Email: i.romano@uniroma.it

Abstract

This collection summarizes significant advancements and challenges in modern vaccine development. Key areas include the rapid deployment of mRNA COVID-19 vaccines, ongoing efforts for universal influenza and malaria vaccines, and progress in tuberculosis, HPV, and dengue vaccine research. Fundamental innovations like adjuvant enhancement and viral vector platforms are crucial. Additionally, breakthroughs in cancer vaccines and the emergence of next-generation technologies promise robust solutions for global health. This body of work underscores a dynamic field continually adapting to address emerging pathogens and chronic diseases.

Citation:   

Copyright:   

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 103
  • [From(publication date): 0-0 - Dec 15, 2025]
  • Breakdown by view type
  • HTML page views: 84
  • PDF downloads: 19
Top Connection closed successfully.